Umibio
Latest round
- Angel
Last raised
- Jul 2022
Total raised
- Undisclosed
Investors
- 2
About Umibio
Established in 2016 and based in Shanghai, China, Umibio is a pharmaceutical company focuses on product research and service development in the direction of gene editing and exosome testing. The company has more than 30 software titles under license. The company's main business is gene editing and exosome detection direction of product research and service development. The company's self-developed exosome products such as engineered exosomes, 293T exosomes, milk exosome extracts, and exosome-specific media.
Who invested in Umibio
2 investors across 1 round
See all investors in Umibio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jul 22, 2022
Amount
Undisclosed
Investors
Questions about Umibio
Who invested in Umibio?
Umibio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Umibio raised?
Umibio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Umibio last raise money?
Umibio's most recent round on record is a Angel, in Jul 2022.
What does Umibio do?
Established in 2016 and based in Shanghai, China, Umibio is a pharmaceutical company focuses on product research and service development in the direction of gene editing and exosome testing.
Where is Umibio headquartered?
Umibio is headquartered in Shanghai, China.
Which VCs invest in companies like Umibio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Umibio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Umibio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.